IMAX Corporation (IMAX) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$35.63
Price Target
$43.00
Target Range
$34.00 — $47.00
Analyst Rating
Buy
Forward P/E21.1x
Trailing P/E56.6x
Forward PEG—
Implied Growth+118.6%
Median Target$44.50
Analyst Spread30.2%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$34
-4.6%
Consensus
$43
+20.7%
Bull Case
$47
+31.9%
IMAX Price Target Analysis
Updated May 8, 2026As of May 8, 2026, IMAX Corporation (IMAX) has a Wall Street consensus price target of $43.00, based on estimates from 25 covering analysts. With the stock currently trading at $35.63, this represents a potential upside of +20.7%. The company has a market capitalization of $1.92B.
Analyst price targets range from a low of $34.00 to a high of $47.00, representing a 30% spread in expectations. The median target of $44.50 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 16 analysts rating the stock as a Buy or Strong Buy,8 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, IMAX trades at a trailing P/E of 56.6x and forward P/E of 21.1x. Analysts expect EPS to grow +118.6% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Communication Services stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+28.5%
Avg Forward P/E16.3x
Peers with Coverage9 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 CNKCinemark Holdings, Inc. | $3.2B | $27.48 | $31.67 | +15.2% | Buy | 13.0x | 31 |
 AMCAMC Entertainment Holdings, Inc. | $930M | $1.52 | $2.00 | +31.6% | Hold | — | 28 |
 RGCRegencell Bioscience Holdings Limited | $15.6B | $31.47 | — | — | Hold | — | 4 |
 MCSThe Marcus Corporation | $569M | $18.26 | $23.00 | +26.0% | Buy | 32.2x | 8 |
 DLXDeluxe Corporation | $1.2B | $26.83 | $27.00 | +0.6% | Buy | 6.6x | 6 |
 DLBDolby Laboratories, Inc. | $5.5B | $57.45 | $85.00 | +48.0% | Buy | 13.3x | 17 |
 NCMINational CineMedia, Inc. | $346M | $3.71 | $7.50 | +102.2% | Hold | — | 17 |
 MANUManchester United plc | $3.3B | $19.13 | $17.95 | -6.2% | Hold | — | 10 |
 WBDWarner Bros. Discovery, Inc. | $68.0B | $27.12 | $29.94 | +10.4% | Hold | — | 32 |
 DISThe Walt Disney Company | $192.6B | $108.72 | $139.50 | +28.3% | Buy | 16.5x | 63 |
Upside Potential Comparison
NCMIDLBAMCDISMCSCNKWBDDLXSee IMAX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IMAX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IMAX vs NFLX
Side-by-side business, growth, and profitability comparison vs Netflix, Inc..
Start ComparisonIMAX — Frequently Asked Questions
Quick answers to the most common questions about buying IMAX stock.
What is the IMAX stock price target for 2026?
The consensus Wall Street price target for IMAX is $43, representing 20.7% upside from the current price of $35.635. With 25 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is IMAX a buy, sell, or hold?
IMAX has a consensus rating of "Buy" based on 25 Wall Street analysts. The rating breakdown is predominantly bullish, with 16 Buy/Strong Buy ratings. The consensus 12-month price target of $43 implies 20.7% upside from current levels.
Is IMAX stock overvalued or undervalued?
IMAX trades at a forward P/E of 21.1484x, representing a moderate valuation. With analysts targeting $43 (20.7% implied move), the stock appears reasonably valued with upside.
How high can IMAX stock go?
The most bullish Wall Street analyst has a price target of $47 for IMAX, while the most conservative target is $34. The consensus of $43 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover IMAX stock?
IMAX is heavily covered by Wall Street, with 25 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 16 have Buy ratings, 8 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the IMAX stock forecast?
The 12-month IMAX stock forecast based on 25 Wall Street analysts shows a consensus price target of $43, with estimates ranging from $34 (bear case) to $47 (bull case). The median consensus rating is "Buy".
What is IMAX's forward P/E ratio?
IMAX trades at a forward P/E ratio of 21.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 56.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy IMAX stock?
Wall Street analysts are very optimistic on IMAX, with a "Buy" consensus rating and $43 price target (20.7% upside). 16 of 25 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do IMAX price targets vary so much?
IMAX analyst price targets range from $34 to $47, a 30% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $43 consensus represents the middle ground.